Market Exclusive

Analyst Activity – HC Wainwright Reiterates Positive on Abeona Therapeutics (NASDAQ:ABEO)

Analyst Ratings For Abeona Therapeutics (NASDAQ:ABEO)

Today, HC Wainwright reiterated its Positive rating on Abeona Therapeutics (NASDAQ:ABEO) with a price target of $30.00.

There are 8 buy ratings on the stock.

The current consensus rating on Abeona Therapeutics (NASDAQ:ABEO) is Buy (Score: 3.00) with a consensus target price of $24.13 per share, a potential 44.46% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For Abeona Therapeutics (NASDAQ:ABEO)
Abeona Therapeutics (NASDAQ:ABEO) has insider ownership of 6.80% and institutional ownership of 38.38%.

Recent Trading Activity for Abeona Therapeutics (NASDAQ:ABEO)
Shares of Abeona Therapeutics closed the previous trading session at with shares trading hands.

Exit mobile version